UNIGE document Scientific Article
previous document  unige:33915  next document
add to browser collection

Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection

Gupta, Mihir
Miller, Christopher J
Baker, Jason V
Lazar, Jason
Bogner, Johannes R
Soliman, Elsayed Z
Neaton, James D
Published in The American journal of cardiology. 2013, vol. 111, no. 5, p. 760-4
Abstract We assessed the relation of inflammatory and coagulation biomarkers with electrocardiographic (ECG) evidence of myocardial ischemia. High-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer levels were measured at study entry for 3,085 human immunodeficiency virus-infected participants (mean age 44 years; 26.4% women; 24.6% black) in the Strategies for Management of Antiretroviral Therapy trial. Logistic regression models were used to examine the associations of these biomarkers with prevalent and incident myocardial ischemia. The latter analyses were performed for 1,411 participants who were randomly assigned to receive continuous antiretroviral therapy during follow-up to suppress the human immunodeficiency virus viral load and had ≥1 ECG reading during the follow-up period. The median hsCRP, IL-6, and D-dimer level was 1.65 μg/ml (interquartile range 0.69 to 4.11), 1.60 pg/ml (interquartile range 1.00 to 2.75), and 0.18 μg/ml (interquartile range 0.11 to 0.32), respectively. At baseline, the prevalence of major or minor Q-QS or ST-T ECG abnormalities was 18.6%. The biomarker levels were associated with prevalent major or minor ischemic abnormalities on the univariate analyses; however, adjustment for traditional risk factors attenuated these associations. The adjusted odds ratio for major or minor ischemic abnormalities and 95% confidence intervals for the greatest versus lowest quartiles was 1.3 (95% confidence interval 0.9 to 1.7) for hsCRP, 1.0 (95% confidence interval 0.7 to 1.3) for IL-6, and 1.1 (95% confidence interval 0.9 to 1.5) for D-dimer. During a median follow-up of 2.3 years, new definite or probable ischemic ECG abnormalities developed in 11.7% of participants receiving continuous antiretroviral therapy. Biomarker levels were not associated with incident abnormalities on unadjusted or adjusted analyses. In conclusion, higher levels of hsCRP, IL-6, and D-dimer were not associated with ischemic ECG abnormalities. Elevated biomarker levels and ECG abnormalities indicating myocardial ischemia might reflect different risk pathways for cardiovascular disease.
Keywords AdultAnti-HIV Agents/therapeutic useBiological Markers/bloodC-Reactive Protein/metabolismCross-Sectional StudiesDNA, Viral/analysisElectrocardiographyFemaleFibrin Fibrinogen Degradation Products/metabolismFollow-Up StudiesHIV/geneticsHIV Infections/blood/complications/drug therapyHumansIncidenceInterleukin-6/bloodMaleMiddle AgedMyocardial Ischemia/blood/complications/epidemiologyOdds RatioPrognosisRisk FactorsUnited States/epidemiology
PMID: 23276469
Full text
Article (Published version) (88 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group VIH/SIDA (930)
(ISO format)
GUPTA, Mihir et al. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection. In: The American journal of cardiology, 2013, vol. 111, n° 5, p. 760-4. doi: 10.1016/j.amjcard.2012.11.032 https://archive-ouverte.unige.ch/unige:33915

458 hits

0 download


Deposited on : 2014-01-30

Export document
Format :
Citation style :